Literature DB >> 10728379

T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes.

S A Huber1.   

Abstract

OBJECTIVE: Enterovirus infections are major etiological factors in myocarditis and dilated cardiomyopathy. Using an experimental murine model of this disease, previous studies have shown that myocarditis susceptibility depends upon activation of T lymphocytes expressing the gamma delta T cell receptor (TcR), and that only mouse strains which accumulate gamma delta T cells in the myocardium show apoptosis of myocytes or evidence of dilated cardiomyopathy-like disease. The objective of the present studies is to demonstrate that gamma delta T cells directly induce greater Fas-dependent apoptosis of cultured myocytes than T cells expressing the alpha beta TcR.
METHODS: Bl.Tg.E alpha mice were infected for 7 days with coxsackievirus B3 (CVB3). Hearts were removed and were either formalin-fixed, sectioned and stained with hematoxylin and eosin for inflammation, and using TdT-TUNEL for apoptosis, or were minced and collagenase digested for isolation of gamma delta+ and alpha beta+ T cells using immunomagnetic bead separation. Neonatal cultures of cardiac myocytes were isolated from mice less than 2 days old by collagenase and pancreatin digestion, and were either untreated or infected with virus. Levels of Fas (CD95) were measured using FITC-conjugated hamster anti-mouse Fas monoclonal antibody and flow cytometry. Susceptibility of myocytes to Fas-dependent killing was measured by 51Cr-release by labeled myocytes incubated for 4 h on either 3T3-mock or 3T3-FasL transfected cell monolayers. Killing by T cells was also measured in a 4 h 51Cr-release assay. Fas-dependent and perforin-dependent cytotoxicity was determined by specific blocking using either Fas-Fc or concanamycin A.
RESULTS: Virally infected myocyte cultures showed significantly enhanced Fas expression compared to uninfected cells, with maximal upregulation of Fas occurring 18-24 h after virus infection. Both infected and uninfected myocytes were selectively killed by FasL-transfected 3T3 cells but not by mock control cells. Approximately 38% of CD3+ lymphocytes isolated from the heart express the gamma delta TcR with the remainder expressing the alpha beta TcR. Both gamma delta+ and alpha beta+ T cells lysed myocyte targets. Blocking studies indicate that gamma delta+ T cells induced predominantly Fas-mediated killing, while alpha beta+ cell produced more perforin-mediated death, although these effectors were capable of Fas-dependent killing as well.
CONCLUSIONS: These studies demonstrate that T cells expressing the gamma delta TcR are more effective mediators of myocyte apoptosis than alpha beta+ T cells in vitro and suggests that these effectors may be primarily responsible for myocardial injury associated with dilated cardiomyopathy-like signs during coxsackievirus B3-induced myocarditis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728379     DOI: 10.1016/s0008-6363(99)00267-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

Review 1.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Critical role for death-receptor mediated apoptotic signaling in viral myocarditis.

Authors:  Roberta L DeBiasi; Bridget A Robinson; J Smith Leser; R Dale Brown; Carlin S Long; Penny Clarke
Journal:  J Card Fail       Date:  2010-11       Impact factor: 5.712

4.  Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.

Authors:  S A Huber; D Sartini
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.

Authors:  Sally A Huber
Journal:  Med Microbiol Immunol       Date:  2004-04-24       Impact factor: 3.402

6.  Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.

Authors:  Sally Ann Huber; Brian Roberts; Mohamad Moussawi; Jonathan E Boyson
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

7.  Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders.

Authors:  Zinaida Dedeić; Gopinath Sutendra; Ying Hu; Kathryn Chung; Elizabeth A Slee; Michael J White; Felix Y Zhou; Robert D Goldin; David J P Ferguson; Debra McAndrew; Jurgen E Schneider; Xin Lu
Journal:  Cell Death Differ       Date:  2018-01-19       Impact factor: 15.828

8.  Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis.

Authors:  Dionne P Robinson; Sally A Huber; Mohamad Moussawi; Brian Roberts; Cory Teuscher; Rebecca Watkins; Arthur P Arnold; Sabra L Klein
Journal:  Biol Sex Differ       Date:  2011-08-01       Impact factor: 5.027

9.  Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.

Authors:  Kapka Miteva; Marion Haag; Jun Peng; Kostas Savvatis; Peter Moritz Becher; Martina Seifert; Katrin Warstat; Dirk Westermann; Jochen Ringe; Michael Sittinger; Heinz-Peter Schultheiss; Carsten Tschöpe; Sophie Van Linthout
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

Review 10.  Oxidative stress and heart failure in altered thyroid States.

Authors:  Pallavi Mishra; Luna Samanta
Journal:  ScientificWorldJournal       Date:  2012-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.